CatalogCOAsQualityShippingContactSign in
NLL Product render coming soon
Coming soon Dual GIP / GLP-1 receptor agonist · Lyophilized powder

Tirzepatide

20 mg

Tirzepatide is a synthetic dual-agonist peptide that binds both the GIP and GLP-1 receptors. It is studied in laboratory contexts for incretin signaling and metabolic pathway research.

Not listed yet. Join the list and we'll email you the moment Tirzepatide goes live, with the signed COA published before launch.

Category: Peptides

Presentation20 mg vial
FormLyophilized
StatusPre-launch
  • Third-party tested
  • COA published before launch
  • Same-day dispatch once live
  • Free shipping over $200
  • Discreet packaging
Third-party testedHPLC + LC-MS purity
Lyophilized & stableSealed, no cold chain
Same-day dispatchDiscreet, tracked shipping
COA on filePublished before listing
01 — Description

What it is

Tirzepatide is a synthetic dual-agonist peptide that binds both the GIP and GLP-1 receptors. It is studied in laboratory contexts for incretin signaling and metabolic pathway research.

Supplied as a lyophilized powder, sealed against light and moisture. Every lot is independently assayed by HPLC and LC-MS, and the signed certificate is published before the compound is listed for sale. Strictly for in vitro laboratory research.

02 — Details

Specifications

FormLyophilized powder
Presentation20 mg single vial
StorageStore lyophilized, protect from light
StatusPre-launch — not yet available

For research use only. Not for human or veterinary use. Not a drug, food, or supplement.

03 — Certificate of analysis

Tested before it's listed

Every Next Level Labs compound ships with a signed certificate of analysis for the exact lot you receive, independently assayed by HPLC and LC-MS. Tirzepatide will publish its COA before it goes on sale. Join the list above to get the report and launch notice together.

Browse published lab reports →